Art. 18 Regulation (EU) 2025/2086

Re-initiation of joint clinical assessments

In forcesince 17 Oct 2025
1.

Where the joint clinical assessment has been discontinued pursuant to Article 10(6) of Regulation (EU) 2021/2282, and where, at the latest five months after the deadline for submission laid down in the Commission’s first request referred to in Article 10(1) of Regulation (EU) 2021/2282, a Member State shares through the HTA IT platform the information, data, analyses and other evidence that formed part of the Commission’s first request, the Commission shall assess whether, based on the information available, the requirements laid down in Article 9(2), (3) and (4), of Regulation (EU) 2021/2282 are met.

2.

The Commission shall provide the results of the assessment referred to in paragraph 1 within 10 working days from the date on which the Member State shared the data referred to in paragraph 1 and as appropriate in consultation with the assessor and co-assessor. The HTA secretariat shall inform the Coordination Group and the health technology developer of the results of the Commission’s assessment.

3.

Where the Coordination Group decides to re-initiate a joint clinical assessment pursuant to Article 10(7) of Regulation (EU) 2021/2282, Article 16 and Article 17(1), (3) and (5), of this Regulation shall apply.

4.

The HTA secretariat shall inform the health technology developer of the re-initiation of a joint clinical assessment.